DK1267924T3 - Immunterapeutiske metoder og sammensætninger - Google Patents

Immunterapeutiske metoder og sammensætninger

Info

Publication number
DK1267924T3
DK1267924T3 DK01929778.7T DK01929778T DK1267924T3 DK 1267924 T3 DK1267924 T3 DK 1267924T3 DK 01929778 T DK01929778 T DK 01929778T DK 1267924 T3 DK1267924 T3 DK 1267924T3
Authority
DK
Denmark
Prior art keywords
antigen presenting
presenting cells
compositions
relates
immunotherapeutic methods
Prior art date
Application number
DK01929778.7T
Other languages
English (en)
Inventor
James Dobbie
Original Assignee
Lamellar Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lamellar Biomedical Ltd filed Critical Lamellar Biomedical Ltd
Application granted granted Critical
Publication of DK1267924T3 publication Critical patent/DK1267924T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK01929778.7T 2000-03-24 2001-03-26 Immunterapeutiske metoder og sammensætninger DK1267924T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0007150.6A GB0007150D0 (en) 2000-03-24 2000-03-24 Immunotherapeutic methods and compositions
PCT/GB2001/001936 WO2001072277A2 (en) 2000-03-24 2001-03-26 Immunotherapeutic methods and compositions

Publications (1)

Publication Number Publication Date
DK1267924T3 true DK1267924T3 (da) 2012-05-29

Family

ID=9888324

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01929778.7T DK1267924T3 (da) 2000-03-24 2001-03-26 Immunterapeutiske metoder og sammensætninger

Country Status (13)

Country Link
US (2) US20040110695A1 (da)
EP (1) EP1267924B1 (da)
JP (1) JP2004517031A (da)
AT (1) ATE544470T1 (da)
AU (2) AU5646101A (da)
CA (1) CA2404325C (da)
DK (1) DK1267924T3 (da)
ES (1) ES2382070T3 (da)
GB (1) GB0007150D0 (da)
NO (1) NO333157B1 (da)
NZ (1) NZ522058A (da)
PT (1) PT1267924E (da)
WO (1) WO2001072277A2 (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
DK1592441T3 (da) * 2003-02-06 2012-05-14 Aduro Biotech Listeria, hvis indtrængen i ikke-phagocytiske celler er svækket, vacciner omfattende listeria og fremgangsmåder til anvendelse deraf
US11324698B2 (en) * 2003-08-28 2022-05-10 Vgsk Technologies, Inc. Sterically stabilized carrier for aerosol therapeutics, compositions and methods for treating the respiratory tract of a mammal
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules
AU2004275550B2 (en) * 2003-09-25 2011-08-18 Lamellar Biomedical Limited Compositions and methods of using lamellar bodies for therapeutic purposes
ATE406874T1 (de) * 2004-07-07 2008-09-15 Statens Seruminstitut Zusammensetzungen und verfahren zur stabilisierung von adjuvans-formulierungen auf lipid-basis unter verwendung von glykolipiden
WO2007130465A2 (en) 2006-05-02 2007-11-15 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
US7465312B2 (en) 2006-05-02 2008-12-16 Green Medical, Inc. Systems and methods for treating superficial venous malformations like spider veins
JP5667180B2 (ja) * 2009-07-01 2015-02-12 イオン メディックス インコーポレイテッド 哺乳類の有核細胞に由来するマイクロベシクル及びその用途
RU2570636C2 (ru) 2010-07-01 2015-12-10 Аэон Медикс Инк Микровезикулы, происходящие из протопластов клеток, и их применение
CN107115314B (zh) * 2011-06-02 2022-04-29 加利福尼亚大学董事会 膜包封的纳米颗粒及使用方法
WO2015021390A2 (en) 2013-08-08 2015-02-12 The Regents Of The University Of California Nanoparticles leverage biological membranes to target pathogens for disease treatment and diagnosis
US20170000875A1 (en) 2013-12-02 2017-01-05 Arytha Biosciences, Llc Toxoid preparation and uses thereof
WO2015143295A2 (en) 2014-03-20 2015-09-24 The Regents Of The University Of California Hydrogel compositions containing toxin-absorbing or binding nanoparticles and uses thereof
WO2015187502A1 (en) 2014-06-02 2015-12-10 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to treat hemolytic diseases and disorders
WO2016109306A1 (en) 2015-01-02 2016-07-07 Cellics Therapeutics, Inc. Use of nanoparticles coated with red blood cell membranes to enable blood transfusion
WO2016176041A1 (en) 2015-04-29 2016-11-03 The Regents Of The University Of California Detoxification using nanoparticles
US20190046444A1 (en) 2015-09-14 2019-02-14 Vgsk Techologies, Inc. A sterically stabilized carrier for subcutaneous, sublingual, and oral therapeutics, compositions and methods for treating a mammal
EP3632410A1 (en) 2018-10-05 2020-04-08 Lamellar Biomedical Limited Lipidic polynucleotide carriers for cellular delivery
EP3692984A1 (en) 2019-02-08 2020-08-12 Deutsches Krebsforschungszentrum, Stiftung des öffentlichen Rechts Annexin-coated particles
AU2022270670A1 (en) 2021-05-05 2023-11-30 Nejat Duzgunes Liposome-encapsulated corticosteriods inhibit sars-cov-2 replication and reduces lung inflammation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925375A (en) * 1987-05-22 1999-07-20 The Liposome Company, Inc. Therapeutic use of multilamellar liposomal prostaglandin formulations
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
US5006343A (en) * 1988-12-29 1991-04-09 Benson Bradley J Pulmonary administration of pharmaceutically active substances
FR2645878B1 (fr) * 1989-04-17 1994-02-25 Institut Nal Sante Recherc Medic Sequences nucleotidiques d'actinomycetales, applications a la synthese ou a la detection d'acides nucleiques, produits d'expression de ces sequences et application en tant que compositions immunogenes
US5088499A (en) * 1989-12-22 1992-02-18 Unger Evan C Liposomes as contrast agents for ultrasonic imaging and methods for preparing the same
ATE164230T1 (de) * 1991-05-29 1998-04-15 Baxter Int 4verfahren und zusammensetzungen zur vorbeugung, diagnose und behandlung seröser entzündungen und damit verbundener störungen
JPH05339169A (ja) * 1992-03-03 1993-12-21 Dai Ichi Seiyaku Co Ltd 経口ワクチン
US5543152A (en) * 1994-06-20 1996-08-06 Inex Pharmaceuticals Corporation Sphingosomes for enhanced drug delivery
US5462752A (en) * 1994-07-28 1995-10-31 Prp, Inc. Inhibition of platelet binding
US5643599A (en) * 1995-06-07 1997-07-01 President And Fellows Of Harvard College Intracellular delivery of macromolecules
JPH11510046A (ja) * 1995-07-21 1999-09-07 ローヌ−プーラン ローラー ファーマシューティカルズ インコーポレイテッド アデノ関連ウイルスリポソーム及び樹状細胞をトランスフェクトして特異性免疫を刺激することにおけるそれらの使用
JP4480800B2 (ja) * 1997-05-08 2010-06-16 オンコシリオン・インコーポレイテッド 活性化ｔ細胞および抗原パルス標識した抗原提示細胞を生成する方法
GB9807298D0 (en) * 1998-04-03 1998-06-03 Britannia Pharmaceuticals Ltd Medicament
EP0976403A1 (en) * 1998-07-30 2000-02-02 Stichting Instituut voor Dierhouderij en Diergezondheid (ID-DLO) Adjuvant comprising pulmonary surfactant
US6290987B1 (en) * 1998-09-27 2001-09-18 Generex Pharmaceuticals, Inc. Mixed liposome pharmaceutical formulation with amphiphiles and phospholipids
US6193997B1 (en) * 1998-09-27 2001-02-27 Generex Pharmaceuticals Inc. Proteinic drug delivery system using membrane mimetics
GB0007150D0 (en) * 2000-03-24 2000-05-17 Lamellar Therapeutics Limited Immunotherapeutic methods and compositions
GB0207653D0 (en) * 2002-04-03 2002-05-15 Lamellar Therapeutics Ltd Methods of using lamellar bodies for therapeutic purposes
GB0322448D0 (en) * 2003-09-25 2003-10-29 Lamellar Therapeutics Ltd Using lamellar bodies to modify linear biological macro molecules

Also Published As

Publication number Publication date
US20080069866A1 (en) 2008-03-20
CA2404325C (en) 2012-06-12
NZ522058A (en) 2005-05-27
EP1267924B1 (en) 2012-02-08
GB0007150D0 (en) 2000-05-17
ES2382070T3 (es) 2012-06-05
CA2404325A1 (en) 2001-10-04
AU2001256461B2 (en) 2005-06-30
NO333157B1 (no) 2013-03-18
WO2001072277A2 (en) 2001-10-04
AU5646101A (en) 2001-10-08
US20040110695A1 (en) 2004-06-10
NO20024571L (no) 2002-10-14
NO20024571D0 (no) 2002-09-24
PT1267924E (pt) 2012-05-24
JP2004517031A (ja) 2004-06-10
ATE544470T1 (de) 2012-02-15
EP1267924A2 (en) 2003-01-02
WO2001072277A3 (en) 2002-06-13

Similar Documents

Publication Publication Date Title
NO20024571D0 (no) Immunoterapeutiske fremgangsmåter og blandinger
PT2351579T (pt) Vacinas polipeptídicas para proteção ampla contra linhagens meningocócicas hipervirulentas
NZ331651A (en) BSW17 peptide immunogens for vaccination against and treatment of allergy
IS4518A (is) Nýtt lyfjaform fyrir bóluefni
NO973250L (no) Preparater for avlevering av antigener
WO2005037190A3 (en) Multiplex vaccines
TR200002930T2 (tr) Kolaylaştırıcı kompozisyonlar
EP0804158A4 (en) PREPARATIONS AND METHOD FOR TRIGGERING CTL IMMUNITY
DK1104306T3 (da) Præparater af CpG- og saponinadjuvanser og fremgangsmåder til anvendelse deraf
AU3847801A (en) Proteosome influenza vaccine
OA09800A (en) Vaccine compositions containing liposomes.
GR3017778T3 (en) Immunogenic complexes, in particular iscoms.
ES2177927T3 (es) Composicion para provocar una reaccion inmunologica a un determinante antigenico no proteinico.
NO994983L (no) Fremgangsmåte for fremstilling av anti-humane antigenreseptorer, samt anvendelse av disse
HUP9901039A2 (hu) Neisseria meningitidis B-csoportba tartozó külső-membrán-fehérjéjének (MB3) expressziója élesztőben, továbbá vakcinák
CA2232344A1 (en) Compositions and methods for enhancing immune responses mediated by antigen-presenting cells
ATE419870T1 (de) Neuer immunogener komplex
AU2002309259A1 (en) Improved polysaccharide and glycoconjugate vaccines_____________
FI955150A0 (fi) OspC-antigeenirokotteiden immunogeenisia formulaatioita lyymisairauden ehkäisyyn ja hoitoon ja rekombinanttimenetelmiä antigeenien valmistamiseksi
WO2004030616A3 (en) Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES
SG146662A1 (en) Method
AU4277996A (en) Presentation of hydrophobic antigens to t-cells by cd1 molecules
WO2004033483A3 (en) Liposomal system and method of using same
ATE385809T1 (de) Saponin-zusammensetzungen und deren verwendung
WO1999047102A3 (en) Methods for enhanced antigen presentation on antigen-presenting cells and compositions produced thereby